4 news items
Enlivex Announces Authorization from the Danish Regulatory Agency for the Company's Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis
ENLV
16 Apr 24
. In addition to evaluating safety, the blinded randomized stage is statistically-powered to assess the efficacy of Allocetra™ injections into the knee
Enlivex Announces Topline Results Of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis
ENLV
11 Apr 24
protocol, the safety and efficacy topline analysis includes sequential organ failure assessment (SOFA) scores and mortality for the 28-day period post
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
ENLV
11 Apr 24
) In accordance with the study protocol, the safety and efficacy topline analysis includes sequential organ failure assessment (SOFA) scores
Enlivex Receives Regulatory Authorization From Israel's Health Ministry For The Initiation Of Phase 1/2 Trial Evaluating Allocetra In Patients With Knee Osteoarthritis
ENLV
26 Feb 24
independent Data Safety Monitoring Board. On top of evaluating the safety, the blinded randomized stage will be statistically powered to assess the efficacy
- Prev
- 1
- Next